# Brad Murray

> Brad Murray, also known professionally as Bradley Murray, is the Boston-based co-founder and CEO of Delve Bio. He previously worked in computational biology at the Broad Institute and Intellia Therapeutics, then in seed and Series A investing at Xontogeny. He holds degrees from Georgetown University and Boston College.

- **Role:** Co-Founder and CEO at Delve Bio
- **Organizations:** Delve Bio, Xontogeny, Intellia Therapeutics, Broad Institute of MIT and Harvard, Georgetown University Office of Technology Commercialization Advisory Board
- **Education:** BS in Biology and Economics, Georgetown University, MBA in Finance and Entrepreneurship, Boston College
- **Known for:** Co-founded Delve Bio and serves as CEO., Led Delve Bio through its public launch with a $35 million Series A led by Perceptive Xontogeny Venture Fund II, with Section 32 and GV participating., Worked across research algorithms, scientific platform development, and early-stage investing.

## Career timeline

- **—** — Worked as a computational associate at the Broad Institute, developing algorithms for genome-sequencing analysis.
- **—** — Spent five years at Intellia Therapeutics in computational biology and platform development.
- **2021** — Listed as a senior associate at Xontogeny in the December 2021 Digital RESI JPM panelist announcement.
- **2022** — Co-founded Delve Bio; a January 2025 conference profile gives 2022 as the company establishment year.
- **2023** — Led Delve Bio at its June 20 public debut with a $35 million Series A.
- **2024** — Announced Delve Bio’s partnership with Broad Clinical Labs in October.
- **2025** — Appeared on David Filby’s Diagnosing Dx podcast to discuss his career and company execution.

## Achievements

- Co-founded Delve Bio and serves as CEO.
- Led Delve Bio through its public launch with a $35 million Series A led by Perceptive Xontogeny Venture Fund II, with Section 32 and GV participating.
- Worked across research algorithms, scientific platform development, and early-stage investing.
- Serves on Georgetown’s Office of Technology Commercialization advisory board.

## Latest updates

- **2026-10** — Delve Bio’s newsroom lists an October 14 announcement expanding its product portfolio; Murray remains listed as founder and CEO on the company team page.

## Links

- Website: https://www.delve.bio/company/
- LinkedIn: https://www.linkedin.com/in/bradley-murray-30646a47

---

Profile page: https://yespress.io/brad-murray
Published by YesPress — https://yespress.io
Last updated: 2026-10-16